Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections
- PMID: 32811557
- PMCID: PMC7431751
- DOI: 10.1186/s13756-020-00796-5
Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections
Abstract
Background: Hospital-acquired bloodstream infection (BSI) is associated with high morbidity and mortality and increases patients' length of stay (LOS) and hospital charges. Our goals were to calculate LOS and charges attributable to BSI and compare results among different models.
Methods: A retrospective observational cohort study was conducted in 2017 in a large general hospital, in Beijing. Using patient-level data, we compared the attributable LOS and charges of BSI with three models: 1) conventional non-matching, 2) propensity score matching controlling for the impact of potential confounding variables, and 3) risk set matching controlling for time-varying covariates and matching based on propensity score and infection time.
Results: The study included 118,600 patient admissions, 557 (0.47%) with BSI. Six hundred fourteen microorganisms were cultured from patients with BSI. Escherichia coli was the most common bacteria (106, 17.26%). Among multi-drug resistant bacteria, carbapenem-resistant Acinetobacter baumannii (CRAB) was the most common (42, 38.53%). In the conventional non-matching model, the excess LOS and charges associated with BSI were 25.06 days (P < 0.05) and US$22041.73 (P < 0.05), respectively. After matching, the mean LOS and charges attributable to BSI both decreased. When infection time was incorporated into the risk set matching model, the excess LOS and charges were 16.86 days (P < 0.05) and US$15909.21 (P < 0.05), respectively.
Conclusion: This is the first study to consider time-dependent bias in estimating excess LOS and charges attributable to BSI in a Chinese hospital setting. We found matching on infection time can reduce bias.
Keywords: Hospital charge; Hospital-acquired bloodstream infection; Length of stay.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.Infect Control Hosp Epidemiol. 2002 Apr;23(4):190-7. doi: 10.1086/502034. Infect Control Hosp Epidemiol. 2002. PMID: 12002233
-
Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults.J Am Geriatr Soc. 2014 Feb;62(2):306-11. doi: 10.1111/jgs.12634. Epub 2014 Jan 17. J Am Geriatr Soc. 2014. PMID: 24438554 Free PMC article.
-
Health care institutional charges associated with ambulatory bloodstream infections in pediatric oncology and stem cell transplant patients.Pediatr Blood Cancer. 2017 Feb;64(2):324-329. doi: 10.1002/pbc.26194. Epub 2016 Aug 24. Pediatr Blood Cancer. 2017. PMID: 27555523
-
Length of stay, cost, and mortality of healthcare-acquired bloodstream infections in children and neonates: A systematic review and meta-analysis.Infect Control Hosp Epidemiol. 2020 Mar;41(3):342-354. doi: 10.1017/ice.2019.353. Epub 2020 Jan 3. Infect Control Hosp Epidemiol. 2020. PMID: 31898557
-
Estimating the impact of healthcare-associated infections on length of stay and costs.Clin Microbiol Infect. 2010 Dec;16(12):1729-35. doi: 10.1111/j.1469-0691.2010.03332.x. Clin Microbiol Infect. 2010. PMID: 20673257 Review.
Cited by
-
Hospital length of stay for COVID-19 patients: a systematic review and meta-analysis.Multidiscip Respir Med. 2022 Aug 9;17(1):856. doi: 10.4081/mrm.2022.856. eCollection 2022 Jan 12. Multidiscip Respir Med. 2022. PMID: 36117876 Free PMC article.
-
Multidrug-Resistant Acinetobacter baumannii May Cause Patients to Develop Polymicrobial Bloodstream Infection.Can J Infect Dis Med Microbiol. 2022 Jun 24;2022:8368578. doi: 10.1155/2022/8368578. eCollection 2022. Can J Infect Dis Med Microbiol. 2022. PMID: 35783362 Free PMC article.
-
Incremental costs of hospital-acquired infections in COVID-19 patients in an adult intensive care unit of a tertiary hospital from a low-resource setting.Antimicrob Resist Infect Control. 2023 Apr 21;12(1):39. doi: 10.1186/s13756-023-01240-0. Antimicrob Resist Infect Control. 2023. PMID: 37085906 Free PMC article.
-
Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.Antimicrob Resist Infect Control. 2021 Jan 22;10(1):19. doi: 10.1186/s13756-021-00888-w. Antimicrob Resist Infect Control. 2021. PMID: 33482916 Free PMC article.
-
Machine-learning based prediction and analysis of prognostic risk factors in patients with candidemia and bacteraemia: a 5-year analysis.PeerJ. 2022 Jun 15;10:e13594. doi: 10.7717/peerj.13594. eCollection 2022. PeerJ. 2022. PMID: 35726257 Free PMC article.
References
-
- Goto M, Al-Hasan M. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501–509. - PubMed
-
- Vrijens F, et al. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs. J Hosp Infect. 2010;75(3):158–162. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources